Nicolas Gaudenzio

CSO at Genoskin

Dr Gaudenzio completed his PhD in 2012 at the University of Toulouse, France, and holds a doctorate in immunology. Following his post-doctorate in the Department of Pathology at Stanford University (CA, USA), he now heads an Inserm cross-disciplinary research group, which was awarded a Starting Grant from the European Research Council (ERC) in 2018. His work has contributed substantially to identifying molecular and cellular targets involved in allergic and non-allergic inflammation and to the development of new imaging methods to probe neuro-immune interactions in preclinical models and in skin samples from patients. His current research work in these fields will contribute to the further comprehension of the role of structural, neuronal and immune cells in the development of skin inflammation and pain, which should help identify new therapeutic options to modulate and prevent disease development. In 2021, Dr Gaudenzio received the prestigious ACTERIA Early Career Research Prize in Allergology awarded every two years by the European Federation of Immunological Societies (EFIS).

Links

Timeline

  • CSO

    Current role